Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients

NCT03090893 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI passed away

Conditions

Antithrombin Deficiency Type 2

Interventions

DRUG: ATryn continuous infusion

Sponsor

Mayo Clinic

Collaborators

[object Object]